• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Markets

Trust the Bounce? I'd Rather Be Late Than Early

There is one key area where I'm more inclined to add right now.
By JAMES "REV SHARK" DEPORRE
Jan 20, 2022 | 10:38 AM EST
Stocks quotes in this article: ARKK, XERS, ALTO, AUPH, MYOV

After an extremely ugly close on Wednesday, there is some bounce action brewing Thursday morning. Buyers are tentative but gaining some confidence the longer that the indexes stay green. Breadth is better than 2 to 1 positive, and new lows are down to around 150 after two days of exceeding 1,000.

Big-cap growth names are leading. Ark Innovation ETF (ARKK) is up 4.6% after hitting a new 12-month low Wednesday, and I have over 30 names on my list of stocks that are up more than 10%.

The main theme appears to be stocking picking in the hardest-hit groups, but you have to wonder how much a bounce can be trusted at this point.

I've done a little buying, but I have my highest level of cash in a long time and am staying patient. I'd rather be late than early. I do think the biotechnology group is near a potential low, so I'm more inclined to add in that sector.

A few names I've added to this morning include Xeris Biopharma Holdings (XERS) , Alto Ingredients (ALTO) , Aurinia Pharamaceuticals (AUPH) , LendingClub LC and Myovant Sciences (MYOV) . I have my eye on other things, but I want to see more sustained strength before I do very much.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long XERS, ALTO, AUPH, LC and MYOV.

TAGS: ETFs | Markets | Small Cap | Trading | Biotechnology | U.S. Equity

More from Markets

Overnight Blood, Didn't It Matter? Snap's Whammy, Trading Bank Stocks and Zoom

Stephen Guilfoyle
May 24, 2022 7:35 AM EDT

There was the 'momentum play' on Monday and not much else as portfolio managers resisted temptation to increase risk exposure.

Bottom Fishing for Biotech Bargains

Bret Jensen
May 23, 2022 11:45 AM EDT

Here are three names I have added to in May.

A Tide-Turning Rally Is Becoming More Probable

Guy Ortmann
May 23, 2022 9:29 AM EDT

The crowd is essentially entirely on the bear side of the boat.

To Position Yourself for a Potential Rally, Keep an Eye on These Stocks

Bob Byrne
May 23, 2022 8:30 AM EDT

While conditions appear favorable for a bear market bounce, let's not ignore the obvious.

The Week Ahead, Indo-Pacific Deal, S&P 500 Valuation, What I've Been Trading

Stephen Guilfoyle
May 23, 2022 7:33 AM EDT

Markets now have a new reversal to think about, but I think I have to be convinced before I can believe.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login